Tamper-Resistant Pseudoephedrine Sparks Pharmacies’ Interest
This article was originally published in The Pink Sheet Daily
Executive Summary
Ohio and West Virginia chain Fruth Pharmacy begins replacing the 30 mg PSE products available in its stores with Acura Pharmaceuticals’ Nexafed product. Meanwhile, DEA says Westport Pharmaceuticals should not make an extraction-proof claim for its Zephrex-D PSE product.